Cytarabine is an antimetabolite chemotherapy agent and pyrimidine nucleoside analogue primarily used as a foundational treatment for acute myeloid leukaemia, acute lymphocytic leukaemia, and various lymphomas.… Read more













Cytarabine is an antimetabolite chemotherapy agent and pyrimidine nucleoside analogue primarily used as a foundational treatment for acute myeloid leukaemia, acute lymphocytic leukaemia, and various lymphomas. To ensure the safety, potency, and stability of this therapeutic agent, pharmaceutical laboratories rely on a comprehensive range of high-quality analytical tools. This category includes reference standards for the Cytarabine active pharmaceutical ingredient (API), alongside a complete selection of pharmacopeial and non-pharmacopeial impurities. These compounds are essential for rigorous impurity profiling, enabling the identification of degradation products formed through hydrolysis, oxidation, or photolysis. Additionally, the collection features metabolites and stable isotope labelled compounds, which serve as critical internal standards for accurate quantification and method validation during complex quality control procedures. By utilizing these characterized reference materials, researchers can maintain compliance with regulatory guidelines throughout the drug development and manufacturing lifecycle.